Skip to main content
Clinical Trials/CTRI/2024/04/065600
CTRI/2024/04/065600
Not yet recruiting
Phase 4

A study comparing recovery characteristics of patients recieving either Sugammadex or Neostigmine and Glycopyrollate, for reversal of rocuronium induced Neuromuscular block - NI

Manipal Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangreneHealth Condition 2: K800- Calculus of gallbladder with acutecholecystitisHealth Condition 3: N920- Excessive and frequent menstruation with regular cycle
Sponsor
Manipal Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists grades 1, 2, and 3 patients aged 18–60 years, coming for elective laparoscopic surgeries (lasting one to three hours) will be recruited for the study.

Exclusion Criteria

  • 1\. Patients with cardiorespiratory abnormalities (New York Heart Association heart failure grades 3 and 4\.
  • 2\. Known allergy to Rocuronium.
  • 3\. Renal insufficiency (eGFR \<60\).
  • 4\. Liver dysfunction (liver enzymes—serum glutamic oxaloacetic transaminase/ serum glutamic pyruvic transaminase values elevated by more than 50% of normal).
  • Underlying neuromuscular disease or the use of drugs known to interfere with neuromuscular transmission.
  • Intraoperative hypothermia (core temperature less than 35°C).
  • Known Emphysema.
  • Unwillingless to perform PFT.

Outcomes

Primary Outcomes

Not specified

Similar Trials